Brief: Immunovant Awarded U.S. Patent For Imvt-1402
March 12 (Reuters) - Immunovant Inc IMVT.O :
* IMMUNOVANT AWARDED U.S. PATENT FOR IMVT-1402
* IMMUNOVANT INC: COMPOSITION OF MATTER PATENT ISSUED WITH
COVERAGE UNTIL JUNE 2043
* IMMUNOVANT INC: PATENT ALSO INCLUDES METHODS OF USE AND
METHODS
OF MANUFACTURING CLAIMS
Source text for Eikon: ID:nGNX1rvcHf
Further company coverage: IMVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunovant
See all newsU.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford
Immunovant falls as drug for thyroid eye disease fails late-stage trials
Immunovant falls as eye disease therapy fails in late-stage studies
Immunovant Q3 net loss smaller than expected
Brief: Immunovant Q3 Net Income USD -110.635 Million Vs. IBES Estimate USD -125.1 Million